Sidra Medicine Launches New Phase in Pediatric Cancer Research 15 November 2023, Doha, Qatar – Sidra Medicine (a QF entity) has initiated a new phase in cancer care, with its pediatric cancer research program, to advance the cutting-edge diagnosis, early detectio… Continue Reading.....

Launch of GMP facility Sidra Medicine Launches Good Manufacturing Practices (GMP) Facility Focus on Precision Medicine in Pediatric Cancers 14 November 2023, Doha, Qatar – Sidra Medicine (a QF entity) today announ… Continue Reading.....

PMFG 2023: Day Three Highlights Launch of new genetic study to enable better fertility treatment and pregnancy outcomes Global advancements in pediatric precision medicine - from genomics to disease modeling 13 November 20… Continue Reading.....

Sidra Medicine PMFG 2023: Day Two Highlights Award of two Path Towards Precision Medicine grants Publication of 1st whole genome sequencing study on Autism 12 November 2023, Doha, Qatar – Precision Medicine and Genomics in Pediatric He… Continue Reading.....

Sidra Medicine PMFG 2023: Day One Highlights Asst. Minister of Health Affairs, Dr. Salih Ali Al Marri at PMFG 2023 Nearly 10,000 families enrolled in research at Sidra Medicine Calls for stronger Arab genome representation to advance prec… Continue Reading.....

Sidra Medicine to host Precision Medicine & Functional Genomics (PMFG) Conference 30 October 2023, Doha, Qatar – Sidra Medicine (a QF entity) will host its 9th annual flagship research conference, Precision Medicine & Functional Genomics (PMFG 2023), from the 11th to the 14th o… Continue Reading.....